Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion type Assertion NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_head.
- NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion description "[To evaluate the predictive value of the disintegrin and metalloproteinases, ADAM-9, ADAM-10, ADAM-11, and ADAM-12, and of the matrix metalloproteinases, MMP-2 and MMP-9, in patients with recurrent breast cancer treated with tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_provenance.
- NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion evidence source_evidence_literature NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_provenance.
- NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion SIO_000772 16243802 NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_provenance.
- NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion wasDerivedFrom befree-20140225 NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_provenance.
- NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_assertion wasGeneratedBy ECO_0000203 NP330435.RA-qaUk6Q1EM9onYdzic12AXPgB9DnYtvfYco515aVUdk130_provenance.